PapersFlow Research Brief
Genetic Neurodegenerative Diseases
Research Guide
What is Genetic Neurodegenerative Diseases?
Genetic neurodegenerative diseases are hereditary disorders characterized by progressive neuronal loss due to genetic mutations, particularly trinucleotide repeats, leading to protein aggregation, polyglutamine toxicity, mitochondrial dysfunction, and RNA-mediated pathology in conditions such as Huntington's disease, myotonic dystrophy, and ataxias.
This field encompasses 82,287 papers examining molecular mechanisms in genetic neurodegenerative diseases, including protein aggregation and trinucleotide repeat expansions. Benson (1999) introduced 'Tandem repeats finder: a program to analyze DNA sequences,' a tool that detects tandem repeats implicated in these diseases. MacDonald (1993) identified the Huntington's disease gene in 'A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes,' highlighting CAG repeat instability.
Topic Hierarchy
Research Sub-Topics
Polyglutamine Toxicity
This sub-topic investigates mechanisms of polyQ expansion-induced neuronal death in Huntington's and related diseases. Researchers study aggregation kinetics, proteostasis impairment, and therapeutic interventions.
Protein Aggregation in Neurodegeneration
This sub-topic covers misfolded protein inclusion formation, clearance pathways, and prion-like propagation. Researchers examine autophagy, ubiquitin-proteasome system, and seeding mechanisms.
Trinucleotide Repeat Expansion
This sub-topic analyzes repeat instability, anticipation, and somatic mosaicism in disorders like Huntington's and myotonic dystrophy. Researchers identify DNA repair defects and modifier genes.
RNA-Mediated Toxicity
This sub-topic explores RNA foci, splicing defects, and microRNA dysregulation in myotonic dystrophy and similar RNAopathies. Researchers study nuclear retention and antisense oligonucleotide therapies.
Mitochondrial Dysfunction in Neurodegeneration
This sub-topic examines bioenergetics failure, calcium handling, and mitophagy defects in genetic neurodegenerative diseases. Researchers link polyQ to respiratory chain impairment and ROS production.
Why It Matters
Genetic neurodegenerative diseases drive research into molecular targets for therapy, as trinucleotide repeat expansions identified by Benson (1999) in 'Tandem repeats finder: a program to analyze DNA sequences' (9,371 citations) enable detection of disease-causing mutations in Huntington's disease and ataxias. The Huntington's gene discovery by MacDonald (1993) in 'A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes' (8,328 citations) provides a basis for genetic testing, affecting over 30,000 patients in the US alone through expanded CAG repeats. Ross and Poirier (2004) in 'Protein aggregation and neurodegenerative disease' (3,415 citations) link aggregates to cell death, informing chaperone and autophagy strategies, while Bjørkøy et al. (2005) in 'p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death' (3,207 citations) demonstrate p62's role in clearing huntingtin aggregates, supporting potential interventions in polyglutamine disorders.
Reading Guide
Where to Start
Start with 'Tandem repeats finder: a program to analyze DNA sequences' by Benson (1999), as it provides foundational tools for identifying trinucleotide repeats central to genetic neurodegenerative diseases like Huntington's and ataxias.
Key Papers Explained
Benson (1999) 'Tandem repeats finder: a program to analyze DNA sequences' enables detection of repeats expanded in MacDonald (1993) 'A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes,' which identifies the HTT gene mutation. Ross and Poirier (2004) 'Protein aggregation and neurodegenerative disease' explains downstream polyglutamine aggregation from such mutations, while Bjørkøy et al. (2005) 'p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death' details autophagic clearance, building a pathway from genetics to proteostasis.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Research centers on polyglutamine toxicity mechanisms and autophagy modulation, as in connections between Ross and Poirier (2004) aggregates and Bjørkøy et al. (2005) p62 protection. No recent preprints available, so frontiers involve applying tandem repeat tools from Benson (1999) to emerging repeat disorders.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Tandem repeats finder: a program to analyze DNA sequences | 1999 | Nucleic Acids Research | 9.4K | ✕ |
| 2 | A novel gene containing a trinucleotide repeat that is expande... | 1993 | Cell | 8.3K | ✓ |
| 3 | Parkinson's disease | 2015 | The Lancet | 5.7K | ✕ |
| 4 | Parkinson's Disease | 2003 | Neuron | 5.4K | ✓ |
| 5 | The functional anatomy of basal ganglia disorders | 1989 | Trends in Neurosciences | 5.3K | ✓ |
| 6 | Dystrophin: The protein product of the duchenne muscular dystr... | 1987 | Cell | 4.6K | ✕ |
| 7 | Primate models of movement disorders of basal ganglia origin | 1990 | Trends in Neurosciences | 3.8K | ✕ |
| 8 | AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELE... | 1991 | Brain | 3.4K | ✕ |
| 9 | Protein aggregation and neurodegenerative disease | 2004 | Nature Medicine | 3.4K | ✕ |
| 10 | p62/SQSTM1 forms protein aggregates degraded by autophagy and ... | 2005 | The Journal of Cell Bi... | 3.2K | ✓ |
Frequently Asked Questions
What causes trinucleotide repeat expansions in genetic neurodegenerative diseases?
Trinucleotide repeats, such as CAG in Huntington's disease, expand and become unstable on affected chromosomes, as shown by MacDonald (1993) in 'A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.' These repeats lead to polyglutamine toxicity and neuronal degeneration. Tools like Benson's (1999) 'Tandem repeats finder: a program to analyze DNA sequences' detect these patterns in DNA.
How does protein aggregation contribute to genetic neurodegenerative diseases?
Protein aggregation forms toxic inclusions in diseases like Huntington's, as detailed by Ross and Poirier (2004) in 'Protein aggregation and neurodegenerative disease.' Aggregates of mutant huntingtin disrupt cellular function and promote neuronal death. Autophagy degrades these via p62/SQSTM1, per Bjørkøy et al. (2005) in 'p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death.'
What is the role of tandem repeats in these diseases?
Tandem repeats are contiguous nucleotide patterns that expand to cause diseases like Huntington's and ataxias, analyzed by Benson (1999) in 'Tandem repeats finder: a program to analyze DNA sequences.' They influence gene expression dysregulation and polyglutamine tracts. Expansions correlate with disease severity and age of onset.
How does autophagy protect against huntingtin toxicity?
p62/SQSTM1 polymerizes to form bodies that bind ubiquitinated aggregates for autophagic degradation, reducing huntingtin-induced cell death, as reported by Bjørkøy et al. (2005) in 'p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death.' This process maintains cellular homeostasis in polyglutamine disorders. Defects in autophagy exacerbate neurodegeneration.
What are key molecular mechanisms in Huntington's disease?
Huntington's disease stems from CAG repeat expansion in the HTT gene, producing toxic polyglutamine tracts, per MacDonald (1993). Protein aggregates form, as in Ross and Poirier (2004) 'Protein aggregation and neurodegenerative disease.' Chaperones and autophagy, including p62, counter this pathology.
Open Research Questions
- ? How do expanded trinucleotide repeats beyond those in Huntington's precisely trigger RNA-mediated toxicity in ataxias and myotonic dystrophy?
- ? What specific chaperone networks fail first in polyglutamine aggregation across different genetic neurodegenerative diseases?
- ? Can autophagy enhancement via p62/SQSTM1 fully mitigate mitochondrial dysfunction in huntingtin-expressing neurons?
- ? Why do certain basal ganglia regions show selective vulnerability in genetic disorders like Huntington's and Parkinson's?
- ? How do tandem repeat variations influence evolutionary roles alongside their disease-causing expansions?
Recent Trends
The field holds steady at 82,287 papers with no 5-year growth data reported.
Core advances remain anchored in highly cited works like Benson 'Tandem repeats finder: a program to analyze DNA sequences' (9,371 citations) and MacDonald (1993) (8,328 citations), with no new preprints or news in the last 12 months indicating stable focus on established mechanisms like protein aggregation and autophagy.
1999Research Genetic Neurodegenerative Diseases with AI
PapersFlow provides specialized AI tools for Neuroscience researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Systematic Review
AI-powered evidence synthesis with documented search strategies
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Genetic Neurodegenerative Diseases with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Neuroscience researchers